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The synthesis of 3-(2-aroylaryloxy)methyl-5-mercapto-4-phenyl-4H-1,2,4-triazole analogues (6a-e)  and 2-(2-
aroylaryloxy)methyl-5-N-phenylamino-1,3,4-thiadiazole (7a-e) were reported earlier. The antioxidant properties of 
these compounds 6a-e and 7a-e were evaluated by DPPH, nitric oxide and hydrogen peroxide radical scavenging 
methods. The investigation of antioxidant screening revealed that some of the tested compounds showed good to 
moderate antioxidant activity. Interestingly, the results show that the compounds containing electron releasing 
groups like methyl and methoxy exhibit good activities. In the above set of compounds 7e, 6e and 6d have shown 
very good antioxidant activity. 
 





The imbalance between reactive oxygen species production and antioxidant defense leads to oxidative stress and 
impairs cell functions, immunity, promotes cell death and DNA damage, which can cause mutations and ultimately 
contribute towards the development of chronic diseases such as cancer [1,2].  Any compound, natural or synthetic 
with antioxidant properties might contribute towards the partial or total alleviation of this type of damage. The 
harmful effect of reactive oxygen species is neutralized by a broad class of protective agents termed antioxidants, 
which prevent oxidative damage by reacting with free radicals before any other molecules can become a target. 
Antioxidants are probably now regarded as the new generation superheroes to maintain the health [3]. There are  
enormous evidences revealing that enrichment of our body systems with antioxidant agents may correct the vitiated 
homeostasis and can prevent the onset as well as treat diseases caused and/or fostered due to free-radical mediated 
oxidative stress. Free radicals can damage tissues and have been implicated in the pathology of many diseases, such 
as cardiovascular diseases, cancer, neurodegenerative diseases, diabetes and ageing [4,5]. In recent years there is an 
increase in the areas related to newer developments in prevention of diseases specially the role of free radicals and 
antioxidants. So it will be pertinent to examine the possible role of ‘free radicals’ in disease and how ‘antioxidants’ 
play an important role in their prevention, especially the current status of the subject matter and future prospects. 
Recently, the search for antioxidant principles that lead to the identification of natural resources, isolation of active 
principles and further modification and refinement of active antioxidant molecules is being accelerated [6]. 
Additionally, there is an increased interest in the application of antioxidants to medical treatment as information is 
constantly gathered linking the development of human diseases to oxidative stress [7].   
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1,2,4-triazoles, 1,3,4-thiadiazole and their  derivatives represent one of the most biologically active classes of 
compounds, which possess a wide spectrum of activities, their nucleus being associated with diverse 
pharmacological activities such as antibacterial [8], antifungal [9], anti-inflammatory [10], analgesic [11], antiviral 
[12], anti tumor [13], antitubercular [14], and anticonvulsant activities [15]. These biological activities prompted us 
to evaluate antioxidant activity of synthesized 1,2,4-triazoles and 1,3,4-thiadiazole analogues [16] by three methods: 
Scavenging of DPPH, nitric oxide and hydrogen peroxide radical activity. 
 
















































































a:  R=CH3, R1=Cl, R2=H
b:  R=CH3, R1=R2=H
 c:  R=CH3, R1=H, R2=Cl
d:  R=CH3, R1=H, R2=OCH3








All solvents and reagents were purchased from Sigma Aldrich Chemicals Pvt Ltd. Melting points were determined 
on an electrically heated VMP-III melting point apparatus. The FT-IR spectra were recorded using KBr discs and 
Nujol on FT-IR Jasco 4100 infrared spectrophotometer. 1H NMR spectra were recorded using Bruker DRX 400 
spectrometer at 400 MHz with TMS as an internal standard. Mass spectra were recorded on LC-MS/MS (API-4000) 
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The strategy employed in the synthesis of desired compounds is as follows (scheme 1). Substituted phenyl benzoates 
(1a-e) on Fries rearrangement using anhydrous aluminum chloride gave corresponding substituted 2-
hydroxybenzophenones (2a-e) in excellent yield [17]. Condensation of 2a-e with ethyl chloroacetate in the presence 
of anhydrous potassium carbonate in dry acetone gave ethyl (2-aroylaryloxy)acetates (3a-e), which on treatment 
with 80% hydrazine hydrate in ethanol yielded the respective 2-(2 aroylaryloxy)acetohydrazides (4a-e). The 
compounds (4a-e) with phenyl isothiocyanate in dry ethanol gave 2-[2-(aroylaryloxy)acetyl]-N-
phenylhydrazinecarbothioamides (5a-e), which on cyclization with 2N sodium hydroxide and anhydrous 
orthophosphoric acid gave 3-(2 aroylaryloxy)methyl-5-mercapto-4-phenyl-4H-1,2,4-triazoles (6a-e) and 2-(2-
aroylaryloxy)methyl-5-N-phenylamino-1,3,4-thiadiazoles (7a-e) analogues respectively in excellent yield [16]. 
 
Biological assay 
In vitro Antioxidant activity 
DPPH free radical scavenging activity: 
The free radical scavenging activities of synthesizes compounds were studied in vitro by their ability to bleach the 
stable radical 2,2-diphenyl-1-picrylhydrazyl (DPPH) [18]. This assay has often been used to estimate the antiradical 
activity of antioxidants. Because of its odd electra, DPPH gives a strong absorption band at 517 nm in visible 
spectroscopy. Stock solution of the drug was diluted to different concentrations in the range of 25, 50, 75, 100 µM in 
methanol. Methanol solution of the synthesized compounds (2ml) was added to methanol solution of DPPH (1ml). 
The samples were kept in the dark for 30 Min after which the optical density was measured at 517 nm and the 
percentage of scavenging activity was calculated. Ascorbic acid was used as standard.  
 
Nitric Oxide (NO) Scavenging Activity:  
The nitric oxide scavenging activity of the synthesized compounds was determined according to the method of 
Green et al [19]. Sodium nitroprusside (5 mM) in phosphate buffer pH 7.4 was incubated with 100 mM 
concentration of test compounds dissolved in a suitable solvent (dioxane/methanol) and tubes were incubated at 25 
oC for 120 min. Control experiment was conducted with equal amount of solvent in an identical manner. At 
intervals, 0.5 ml of incubation solution was taken and diluted with 0.5 ml of Griess reagent (1% Sulfanilamide, 0.1% 
N-naphthylethylenediamine dihydrochloride and 2% o-phosphoric acid dissolved in distilled water). The absorbance 
of the chromophore formed during diazotization of nitrite with sulfanilamide and subsequent N-
naphthylethylenediamine dihydrochloride was measured at 546 nm.  
 
Hydrogen peroxide scavenging activity:  
The H2O2 scavenging ability of the synthesized compounds was determined spectrophotometrically according to the 
method of Ruch. et al [20].  Briefly, a solution of hydrogen peroxide (2 mM) was prepared in 0.17 M phosphate 
buffer (pH 7.4). Various concentrations of the samples (in methanol) were added to the reaction mixture containing 
2 mM hydrogen peroxide. After 10 min incubation at room temperature, the absorbance was measured against a 
blank at 230 nm.  
 
The inhibition ratio (I %) of all the tested compounds was calculated according to the following equation: I % = 
(Ac-As) / Ac × 100, where Ac is the absorbance of the control and As is the absorbance of the sample. The radical 
scavenging activity was expressed as IC50 which was determined from the plot of percentage inhibition against 
concentration (µM/ml). All the tests and analyses were done in triplicate and the results were averaged. 
 
RESULTS AND DISCUSSION 
 
Antioxidant activity 
All the compounds were screened for in vitro antioxidant activity by various scavenging methods like DPPH, nitric 
oxide and hydrogen peroxide radical activity. In vitro antioxidant activating of synthesized compounds are 
summarized in Tables (1, 2 & 3). 
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Table 1. In-vitro antioxidant activity of compounds 6a-e and 7a-e in DPPH method 
 
Compound Concentration (µg/ml) 25 50 75 100 IC50 
6a 56.25±1.84 62.39±1.09 65.64± 0.98 71.67± 1.69 22.31± 1.38 
6b 69.99±1.07 72.58± 0.88 77.32± 1.33 82.48±1.06 19.15± 1.08 
6c 65.34±1.45 69.33±1.22 74.62± 1.57 78.25±0.96 19.89± 1.14 
6d 74.24± 0.20 78.12± 0.46 79.98± 0.47 84.53± 0.71 17.31± 0.61 
6e 73.62± 0.37 76.57±0.61 79.46± 0.71 84.53± 0.87 17.99± 0.53 
7a 60.41±1.18 65.76± 1.25 69.52±0.89 73.64± 0.96 21.36± 0.77 
7b 69.11± 1.27 73.64± 1.42 75.44± 1.57 80.36±1.05 19.52± 1.11 
7c 65.31±1.06 70.24± 1.41 74.22± 0.83 78.25± 1.64 20.23±1.08 
7d 71.42±0.27 77.17±0.44 78.32± 0.66 82.58± 0.71 18.13± 0.7 
7e 77.36± 0.29 80.31± 0.50 84.16± 0.62 86.35± 0.79 17.24± 0.29 
Ascorbic acid 81.98±0.11 82.99±0.37 84.88±0.43 86.79±0.52 14.98±0.43 
Blank - - - - - 
(-) Showed no scavenging activity. Values were the means of three replicates ±SD. 
 
Table 2. In- vitro antioxidant activity of compounds 6a-e and 7a-e in nitric oxide (NO) method. 
 
Compound Concentration (µg/ml) 25 50 75 100 IC50 
6a 61.46±1.53 62.25± 1.22 68.94± 1.32 73.63±0.72 20.99 ± 0.95 
6b 72.64± 0.89 75.42± 1.08 78.36± 1.42 83.26± 1.28 18.22± 0.96 
6c 69.63±0.91 71.84± 1.40 75.74± 0.96 81.73± 1.23 19.99± 1.07 
6d  76.48 ± 0.27  80.71 ± 0.38 83.26 ± 0.58 86.65 ± 0.75 16.89 ± 0.57 
6e 74.68 ± 0.27  79.38 ± 0.46 83.77 ±0.63 85.41 ± 0.80 17.97 ± 1.0 
7a 63.84 ± 1.42  67.35 ± 1.57 71.72 ± 0.79 74.33 ±1.08 20.51± 0.98 
7b 73.29 ± 0.86  75.47 ±0.95 79.64 ± 1.07 83.72 ± 1.42 18.63 ± 0.57 
7c 64.74 ± 1.33  72.81 ± 1.25 77.82 ±1.05 79.26± 0.80 20.11 ± 1.13 
7d 72.52±0.178  77.61 ± 0.36 80.33 ± 0.55 84.95 ±0.70 17.23 ± 1.16 
7e 79.48 ± 0.29  84.81 ± 0.48 85.76 ± 0.62 87.44 ± 0.81 16.67 ± 0.78 
Ascorbic acid 83.63±0.17 84.65±0.35 87.54±0.51 89. 97±0.68 13.97±0.54 
Blank - - - - - 
(-) Showed no scavenging activity. Values were the means of three replicates ±SD. 
 
Table 3. In vitro antioxidant activity of compounds 6a-e and 7a-e in hydrogen peroxide (H2O2) method. 
 
Compounds Concentration (µg/ml) 25 50 75 100 IC50 
6a 52.84 ± 1.17 55.31± 0.87 59.60± 0.98 64.31± 0.64 25.44 ± 1.05 
6b 62.51± 0.87 64.72± 1.59 69.51± 1.08 72.60 ± 1.38 20.10± 1.24 
6c 59.72±1.14 63.79± 1.18 66.66 ± 1.48 70.23± 1.56 21.99± 1.08 
6d 64.33± 0.31 66.74± 0.47 69.51±0.66 73.49± 0.79 19.98± 1.27 
6e 67.40± 1.13 70.66± 1.32 72.41± 0.61 75.45± 0.72 18.88± 0.61 
7a 54.26± 0.90 57.13± 1.40 60.25 ± 0.79 65.64± 1.06 24.79± 0.43 
7b 61.57±1.07 64.28± 1.28 68.35± 1.58 71.33± 0.84 21.10± 0.53 
7c 69.34± 0.29 72.31 ± 0.46 75.22± 0.62 80.25± 0.83 19.68± 0.96 
7d 65.55± 0.28 68.26± 0.65 70.24± 0.70 73.41± 0.81 20.20± 0.27 
7e 69.50± 0.29 72.33±0.46 75.26± 0.62 80.72± 0.83 19.05± 0.96 
Ascorbic acid 75.96±0.17 77.75±0.32 81.48±0.60 85.62±0.70 15.73±0.25 
Blank - - - - - 
(-) Showed no scavenging activity. Values were the means of three replicates ±SD 
 
The investigation of antioxidant screening revealed that some of the tested compounds showed good to moderate 
antioxidant activity. Particularly, compounds 7e, 6d, 6e, 7d, 6b and 7b have shown the best antioxidant activity with 
IC50 values of 17.24, 17.31, 17.99, 18.13, 19.15 and 19.52 µg/ml respectively, and 6c, 7c, 6a and 7a showed 
moderate activity as compared to the standard, ascorbic acid by DPPH. Further nitric oxide activity methods have 
little different scavenging activity. Mainly, compounds 7e, 6d, 7d, 6e, 6b and 7b have shown the best antioxidant 
activity with IC50 values of 16.67,  16.89, 17.23, 17.97, 18.22 and 18.63 µg/ml  respectively, In hydrogen peroxide 
IC50 values of compounds 6e, 7e, 7c and 6d have showed good activities. In general, compounds 6e and 7e with 
methyl group and 6d and 7d with methoxy group at para position of benzoyl ring have shown highest activity 
compared to other analogues. 
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The strong antioxidant activity of these compounds indicated their potential application in the drug development, 





The present work describes the antioxidant activity of compounds 6a-e and 7a-e by DPPH, nitric oxide and 
hydrogen peroxide radical scavenging methods. The investigation of antioxidant screening revealed that some of the 
tested compounds showed good to moderate antioxidant activity. In general, compounds 6e and 7e with methyl 
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